14-day Premium Trial Subscription Try For FreeTry Free
Date Action Amount Person Type
Dec 21, 2023 Buy 670 000 Valentine Troy Common Stock
Dec 21, 2023 Buy 100 000 Widdows Peter Common Stock
Dec 21, 2023 Buy 1 340 000 Latham Joel Common Stock
Dec 21, 2023 Buy 100 000 Anastassov George Common Stock
Dec 21, 2023 Buy 100 000 Clark Robert Common Stock
Nov 28, 2023 Sell 25 000 Clark Robert Stock Option (right to buy)
Nov 28, 2023 Sell 25 000 Clark Robert Stock Option (right to buy)
Nov 28, 2023 Buy 0 Anastassov George Common Stock
Nov 28, 2023 Buy 0 Valentine Troy Common Stock
Nov 28, 2023 Buy 0 Valentine Troy Common Stock
Nov 28, 2023 Buy 0 Valentine Troy Common Stock
Nov 28, 2023 Buy 0 Valentine Troy Common Stock
Nov 28, 2023 Buy 0 Valentine Troy Common Stock
Nov 28, 2023 Buy 2 960 Valentine Troy Stock Option (right to buy)
Nov 28, 2023 Buy 4 667 Valentine Troy Stock Option (right to buy)
Nov 28, 2023 Buy 4 667 Valentine Troy Stock Option (right to buy)
Nov 28, 2023 Buy 4 667 Valentine Troy Stock Option (right to buy)
Nov 28, 2023 Buy 1 951 Valentine Troy Stock Option (right to buy)
Nov 28, 2023 Buy 2 500 Clark Robert Stock Option (right to buy)
Nov 28, 2023 Buy 2 500 Clark Robert Stock Option (right to buy)
Nov 28, 2023 Buy 0 Widdows Peter Common Stock
Nov 28, 2023 Buy 11 050 Widdows Peter Stock Option (right to buy)
Nov 28, 2023 Buy 0 Bhalla Madhukar
Nov 28, 2023 Buy 0 Changoer Lekhram Common Stock
Nov 28, 2023 Buy 0 Swan Joseph Common Stock
Nov 28, 2023 Buy 1 000 Swan Joseph Stock Option (right to buy)
Nov 28, 2023 Buy 1 000 Swan Joseph Stock Option (right to buy)
Nov 28, 2023 Buy 1 000 Swan Joseph Stock Option (right to buy)
Nov 28, 2023 Buy 0 Latham Joel Common Stock
Nov 28, 2023 Buy 7 500 Latham Joel Stock Option (right to buy)
Nov 28, 2023 Buy 9 334 Latham Joel Stock Option (right to buy)
Nov 28, 2023 Buy 9 334 Latham Joel Stock Option (right to buy)
Nov 28, 2023 Buy 9 334 Latham Joel Stock Option (right to buy)
Nov 28, 2023 Buy 15 833 Latham Joel Stock Option (right to buy)
INSIDER POWER
78.312
Last 34 transactions
Buy: 2 399 297 | Sell: 50 000 (Shares)

Based on the 34 latest insides trades, we have calculated the insider power to be positive at a ratio of 78.312.

In total, the insiders bought 2 399 297 and sold 50 000 IXHL shares in the last 34 trades.

Click to get the best stock tips daily for free!

About Incannex Healthcare Limited

Incannex Healthcare Limited Incannex Healthcare Limited engages in the research, development, and sale of medicinal cannabinoid products in Australia. It offers pharmaceutical grade cannabinoid products under the Incannex brand name. The company's products include IHL-42X, which is in Phase II clinical trials for obstructive sleep apnea; IHL-216A for traumatic brain injury; and IHL-675A, a combination of hydroxychloroquine and cannabidiol for the prevention and treatment of... IXHL Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT